Cancer Cachexia Market Report 2023-2028 Growth, Demand and Challenges of the Key Industry Players

1
Cancer Cachexia Market Report 2023 By
Therapeutics, Mode Of Action and Distribution
Channel Key Regions and Competitive Landscape
www.imarcgroup.com
Sales_at_imarcgroup.com
1-631-791-1145




Author Elena Anderson, Marketing Manager
IMARC Group
Copyright IMARC Service Pvt Ltd. All Rights
Reserved
2019 IMARC All Rights Reserved
2
About IMARC Group
Report Description
The International Market Analysis Research and
Consulting Group is a leading adviser on
management strategy and market research
worldwide. We partner with clients in all sectors
and regions to identify their highest-value
opportunities, address their most critical
challenges, and transform their
businesses. IMARCs information products include
major market, scientific, economic and
technological developments for business leaders
in pharmaceutical, industrial, and high
technology organizations. Market forecasts and
industry analysis for biotechnology, advanced
materials, chemicals, food and beverage, travel
and tourism, nanotechnology and novel processing
methods are at the top of the companys
expertise. IMARCs tailored approach combines
unfathomable insight into the dynamics of
companies and markets with close cooperation at
all levels of the client organization. This
ensures that our clients achieve unmatchable
competitive advantage, build more proficient
organizations, and secure lasting results.
3
Report Description and Highlights
Report Description
Global Cancer Cachexia Market Outlook
2023-2028 The global cancer cachexia market
size reached US 2.0 Billion in 2022. Looking
forward, IMARC Group expects the market to reach
US 2.6 Billion by 2028, exhibiting a growth rate
(CAGR) of 4.5 during 2023-2028. Cancer cachexia
is a complex and multifactorial syndrome
characterized by the loss of skeletal muscle
mass, asthenia, negative protein balance, loss of
appetite, and anemia. It shows symptoms of
decreased secretion of host anabolic hormones and
abnormalities in protein, lipid, and carbohydrate
metabolism. It is divided into three stages,
which include pre-cachexia, cachexia, and
refractory cachexia. It generally occurs in
patients with pancreatic and lung cancer,
tuberculosis (TB), chronic renal failure,
obstructive pulmonary disease (COPD), and human
immunodeficiency virus (HIV). It can be treated
with combination therapy and various approaches,
including diet modification, nutritional
supplements, adapted exercise, and medications
that decrease inflammation.
4
Report Description and Highlights
Report Description
Global Cancer Cachexia Market Trends At
present, the rising prevalence of liver, lung,
pancreatic, and other cancers, along with the
increasing aging population, is catalyzing the
demand for medications and therapies to prevent
cancer cachexia. In addition, the growing
awareness among the masses about the benefits of
early diagnosis and the availability of novel
therapeutic drugs to prevent the severity of
cancer is positively influencing the market.
Apart from this, the introduction of numerous
nutritional and appetite stimulants, such as
megestrol acetate, dexamethasone, and
methylprednisolone, is creating a positive market
outlook. Moreover, the increasing number of
hospitals and healthcare centers, coupled with
significant technological advancements in the
healthcare industry, is propelling the growth of
the market. Request for a free sample report
https//www.imarcgroup.com/cancer-cachexia-market/
requestsample

5
Report Description and Highlights
Report Description

• Market Summary
• Breakup by Therapeutics
• Progestogens
• Corticosteroids
• Combination Therapy
• Others
• Breakup by Mode of Action
• Appetite Stimulators
• Weight Loss Stabilizers

6
Report Description and Highlights
Report Description

• Breakup by Distribution Channel
• Hospital Stores
• Retail Pharmacy
• Online Pharmacy
• Breakup by Region
• North America
• Europe
• Asia Pacific
• Middle East and Africa
• Latin America
• On account of the aforementioned factors, the
  market is anticipated to witness strong growth
  during 2023-2028.

7
Report Description and Highlights
Report Description

• Competitive Landscape With Key player
• AAVogen Inc.
• Actimed Therapeutics Ltd.
• Aphios Corporation
• Artelo Biosciences Inc.
• AVEO Pharmaceuticals Inc.
• Fresenius Kabi AG
• Helsinn Healthcare SA
• Merck Co. Inc.
• NGM Biopharmaceuticals Inc.
• Pfizer Inc.
• Tetra Bio-Pharma
• View Report TOC, Figures and Tables
  https//www.imarcgroup.com/cancer-cachexia-market

8
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
9
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
10
Report Description and Highlights
Report Description

2019 IMARC All Rights Reserved This
Publication and all its contents unless
otherwise mentioned are copyrighted in the name
of International Market Analysis Research and
Consulting (IMARC). No part of this publication
may be reproduced, repackaged, redistributed or
resold in whole or in any part. The publication
may also not be used in any form or by and means
graphic electronic or mechanical, including
photocopying, recording, taping or by information
storage or retrieval, or by any other form,
without the express consent of International
Market Analysis Research and Consulting
(IMARC). Disclaimer All contents and data of
this publication, including forecasts, data
analysis and opinion have been based on
information and sources believed to be accurate
and reliable at the time of publishing.
International Market Analysis Research and
Consulting makes no representation of warranty of
any kind as to the accuracy or completeness of
any Information provided. IMARC accepts no
liability whatsoever for any loss or damage
resulting from opinion, errors or inaccuracies if
any found this publication. IMARC, IMARC Group
and Global Therapy Insight Series are registered
trademarks of International Market Analysis
Research and Consulting. All other trademarks
used in this publication are registered
trademarks of their respective companies.
11

Contact Us